Cargando…
Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library
This report describes the discovery and characterization of antibodies with potential broad SARS-CoV-2 neutralization profiles. The antibodies were obtained from a phage display library built with the VH repertoire of a convalescent COVID-19 patient who was infected with SARS-CoV-2 B.1.617.2 (Delta)...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883901/ https://www.ncbi.nlm.nih.gov/pubmed/35225871 http://dx.doi.org/10.3390/antib11010013 |
_version_ | 1784660038533513216 |
---|---|
author | Mendoza-Salazar, Ivette Gómez-Castellano, Keyla M. González-González, Edith Gamboa-Suasnavart, Ramsés Rodríguez-Luna, Stefany D. Santiago-Casas, Giovanni Cortés-Paniagua, María I. Pérez-Tapia, Sonia M. Almagro, Juan C. |
author_facet | Mendoza-Salazar, Ivette Gómez-Castellano, Keyla M. González-González, Edith Gamboa-Suasnavart, Ramsés Rodríguez-Luna, Stefany D. Santiago-Casas, Giovanni Cortés-Paniagua, María I. Pérez-Tapia, Sonia M. Almagro, Juan C. |
author_sort | Mendoza-Salazar, Ivette |
collection | PubMed |
description | This report describes the discovery and characterization of antibodies with potential broad SARS-CoV-2 neutralization profiles. The antibodies were obtained from a phage display library built with the VH repertoire of a convalescent COVID-19 patient who was infected with SARS-CoV-2 B.1.617.2 (Delta). The patient received a single dose of Ad5-nCoV vaccine (Convidecia™, CanSino Biologics Inc.) one month before developing COVID-19 symptoms. Four synthetic VL libraries were used as counterparts of the immune VH repertoire. After three rounds of panning with SARS-CoV-2 receptor-binding domain wildtype (RBD-WT) 34 unique scFvs, were identified, with 27 cross-reactive for the RBD-WT and RBD Delta (RBD-DT), and seven specifics for the RBD-WT. The cross-reactive scFvs were more diverse than the RBD-WT specific ones, being encoded by several IGHV genes from the IGHV1 and IGHV3 families combined with short HCDR3s. Six cross-reactive scFvs and one RBD-WT specific scFv were converted to human IgG1 (hIgG1). Out of the seven antibodies, six blocked the RBD-WT binding to angiotensin converting enzyme 2 (ACE2), suggesting these antibodies may neutralize the SARS-CoV-2 infection. Importantly, one of the antibodies also recognized the RBD from the B.1.1.529 (Omicron) isolate, implying that the VH repertoire of the convalescent patient would protect against SARS-CoV-2 Wildtype, Delta, and Omicron. From a practical viewpoint, the triple cross-reactive antibody provides the substrate for developing therapeutic antibodies with a broad SARS-CoV-2 neutralization profile. |
format | Online Article Text |
id | pubmed-8883901 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88839012022-03-01 Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library Mendoza-Salazar, Ivette Gómez-Castellano, Keyla M. González-González, Edith Gamboa-Suasnavart, Ramsés Rodríguez-Luna, Stefany D. Santiago-Casas, Giovanni Cortés-Paniagua, María I. Pérez-Tapia, Sonia M. Almagro, Juan C. Antibodies (Basel) Article This report describes the discovery and characterization of antibodies with potential broad SARS-CoV-2 neutralization profiles. The antibodies were obtained from a phage display library built with the VH repertoire of a convalescent COVID-19 patient who was infected with SARS-CoV-2 B.1.617.2 (Delta). The patient received a single dose of Ad5-nCoV vaccine (Convidecia™, CanSino Biologics Inc.) one month before developing COVID-19 symptoms. Four synthetic VL libraries were used as counterparts of the immune VH repertoire. After three rounds of panning with SARS-CoV-2 receptor-binding domain wildtype (RBD-WT) 34 unique scFvs, were identified, with 27 cross-reactive for the RBD-WT and RBD Delta (RBD-DT), and seven specifics for the RBD-WT. The cross-reactive scFvs were more diverse than the RBD-WT specific ones, being encoded by several IGHV genes from the IGHV1 and IGHV3 families combined with short HCDR3s. Six cross-reactive scFvs and one RBD-WT specific scFv were converted to human IgG1 (hIgG1). Out of the seven antibodies, six blocked the RBD-WT binding to angiotensin converting enzyme 2 (ACE2), suggesting these antibodies may neutralize the SARS-CoV-2 infection. Importantly, one of the antibodies also recognized the RBD from the B.1.1.529 (Omicron) isolate, implying that the VH repertoire of the convalescent patient would protect against SARS-CoV-2 Wildtype, Delta, and Omicron. From a practical viewpoint, the triple cross-reactive antibody provides the substrate for developing therapeutic antibodies with a broad SARS-CoV-2 neutralization profile. MDPI 2022-02-10 /pmc/articles/PMC8883901/ /pubmed/35225871 http://dx.doi.org/10.3390/antib11010013 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mendoza-Salazar, Ivette Gómez-Castellano, Keyla M. González-González, Edith Gamboa-Suasnavart, Ramsés Rodríguez-Luna, Stefany D. Santiago-Casas, Giovanni Cortés-Paniagua, María I. Pérez-Tapia, Sonia M. Almagro, Juan C. Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library |
title | Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library |
title_full | Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library |
title_fullStr | Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library |
title_full_unstemmed | Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library |
title_short | Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library |
title_sort | anti-sars-cov-2 omicron antibodies isolated from a sars-cov-2 delta semi-immune phage display library |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883901/ https://www.ncbi.nlm.nih.gov/pubmed/35225871 http://dx.doi.org/10.3390/antib11010013 |
work_keys_str_mv | AT mendozasalazarivette antisarscov2omicronantibodiesisolatedfromasarscov2deltasemiimmunephagedisplaylibrary AT gomezcastellanokeylam antisarscov2omicronantibodiesisolatedfromasarscov2deltasemiimmunephagedisplaylibrary AT gonzalezgonzalezedith antisarscov2omicronantibodiesisolatedfromasarscov2deltasemiimmunephagedisplaylibrary AT gamboasuasnavartramses antisarscov2omicronantibodiesisolatedfromasarscov2deltasemiimmunephagedisplaylibrary AT rodriguezlunastefanyd antisarscov2omicronantibodiesisolatedfromasarscov2deltasemiimmunephagedisplaylibrary AT santiagocasasgiovanni antisarscov2omicronantibodiesisolatedfromasarscov2deltasemiimmunephagedisplaylibrary AT cortespaniaguamariai antisarscov2omicronantibodiesisolatedfromasarscov2deltasemiimmunephagedisplaylibrary AT pereztapiasoniam antisarscov2omicronantibodiesisolatedfromasarscov2deltasemiimmunephagedisplaylibrary AT almagrojuanc antisarscov2omicronantibodiesisolatedfromasarscov2deltasemiimmunephagedisplaylibrary |